Ibezapolstat: Clinical Trials

2 trials of Ibezapolstat, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow Ibezapolstat: new trials by email Literature Review of Ibezapolstat trials Research Report on Ibezapolstat

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Ibezapolstat - Clostridium Difficile Infection Recurrence
Phase 2RecruitingAcurx Pharmaceuticals Inc.202026-09-252026-11-13
ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection
Ibezapolstat, Vancomycin - Clostridium Difficile Infection
Phase 2CompletedAcurx Pharmaceuticals Inc.532020-03-062025-01-17

Conditions studied

Clostridium Infections (1)

Sponsors

Acurx Pharmaceuticals Inc. (2)

Countries

United States (2)

Top investigators

Michael H Silverman, MD (1)

Results publications

PMID 35134880, PMID 40516571